Related Experiment Video
Updated: Jul 10, 2026

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies
Published on: March 8, 2024
Combined heart-kidney transplantation: the University of Wisconsin experience
Joshua L Hermsen1, Dilip S Nath, Alejandro Munoz del Rio
1Division of Cardiothoracic Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53791-7375, USA. hermsen@surgery.wisc.edu
Insights
Combined heart-kidney transplantation (HKTx) shows survival rates comparable to single-organ transplants. This approach may offer an immunologic advantage, warranting further investigation for optimal recipient selection.
Area of Science:
- Transplantation Medicine
- Immunology
- Cardiology
- Nephrology
Background:
- Combined heart-kidney transplantation (HKTx) is a growing procedure.
- Long-term outcomes and comparative analyses for HKTx are limited.
Purpose of the Study:
- To compare long-term outcomes of HKTx with single-organ heart or kidney transplantation.
- To evaluate patient and graft survival, rejection rates, and coronary allograft vasculopathy (CAV) in HKTx recipients.
Main Methods:
- Retrospective review of prospectively collected data from 19 HKTx patients.
- Comparison of HKTx outcomes against heart-only (n=515), kidney-only (n=3,188), and simultaneous separate transplants (n=8).
- Analysis included patient/graft survival, rejection episodes, and CAV incidence.
Main Results:
- No significant difference in patient or graft survival between HKTx and control groups.
- Significantly prolonged time to first rejection episode for both organs in HKTx compared to single-organ recipients.
- Significantly lower incidence of coronary allograft vasculopathy (CAV) in HKTx patients.
Conclusions:
- HKTx demonstrates outcomes similar to solitary heart or kidney transplantation.
- Combined organ transplantation may confer an immunologic advantage.
- While medically appropriate, refined strategies are needed to identify optimal HKTx recipient populations.
Background:
Combined heart-kidney transplantation (HKTx) is increasing in frequency, but long-term outcomes are unknown and appropriately comparative analysis is lacking.
Methods:
This study was a retrospective review of prospectively collected data for 19 HKTx patients. Patient and graft survival, graft rejection and coronary allograft vasculopathy (CAV) were compared for HKTx vs recipients of a heart (n = 515) or kidney alone (n = 3,188) or both organs at separate time-points (n = 8).
Results:
Patient and graft survival did not differ for HKTx vs any group. HKTx time to first rejection episode was significantly prolonged for both organs vs single-organ recipients. The incidence of CAV was significantly lower for HKTx.
Conclusions:
HKTx provides outcomes similar to those for solitary heart or kidney transplantation. There may be an immunologic advantage to receiving organs in a combined fashion. Such allocation of organs seems medically appropriate; however, more refined strategies are needed to identify optimal recipient populations.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure

